David Ingbar
Professor, Divisions of Pediatrics, and Integrative Biology and Physiology, and Pulmonary, Allergy, Critical Care, and Sleep Medicine · University of Minnesota
Credentials: · · · · ·
History
- Present
- 1981–1984
Pulmonary Disease and Critical Care Medicine
- 1978–1981
Internal Medicine
- 1974–1978
Research
Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis
Experimental Cell Research · 1994 · 265 citations
Role of mesenchymal cell death in lung remodeling after injury
Journal of Clinical Investigation · 1993 · 179 citations
The critical care crisis in the United States: a report from the profession
Chest · 2004 · 162 citations
18 papers
13 papers
- PB
13 papers
7 papers
6 papers
5 papers
- LN
4 papers
- HK
3 papers
Grants
- 2024–2029
CTSA K12 Program at University of Minnesota
National Center for Advancing Translational Sciences · K12
Contact PI · $3.2M · University of Minnesota
- 1994–2025
National Heart, Lung, and Blood Institute · T32
Contact PI · $12.3M · University of Minnesota
- 2018–2024
Institutional Career Development Core
National Center for Advancing Translational Sciences · KL2
Contact PI · $6.3M · University of Minnesota
- 2009–2015
National Heart, Lung, and Blood Institute · P01
Project lead · $1.5M · University of Minnesota
Clinical trials
- 2020–2024
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Principal investigator · Completed · Phase 2
Masonic Cancer Center, University of Minnesota
- 2026–2031
Study chair · Withdrawn · Phase 2
University of Minnesota
- 2020–2026
Treatment of ARDS With Instilled T3
Study chair · Active not recruiting · Phase 2
University of Minnesota